10+ can't miss Houston business and innovation events for July

WHERE TO BE

Don't miss these July events — from meetups to hackathons. Photo via Getty Images

From networking meetups to expert speaker summits, July is filled with opportunities for Houston innovators.

Here's a roundup of events you won't want to miss out on so mark your calendars and register accordingly.

Note: This post may be updated to add more events.

July 4 — Houston Blockchain Alliance Monthly Meetup

Check out the Houston Blockchain Alliance Monthly Meetup at The Cannon, in partnership with Lucrisma, Event Horizon Capital, and CryptoEQ. This in-person event is a great opportunity to connect with fellow blockchain enthusiasts in the Houston area. Whether you're a beginner or an expert, come and engage in lively discussions, share insights, and network with like-minded individuals.

This event is Thursday, July 4, from 5:30 to 7:30 pm at The Cannon. Click here to register.

July 9 — Software Day at the Ion: An Intro to Central Texas Seed Stage VCs

Over the course of 2-hours, first-time entrepreneurs looking for guidance or seasoned founders needing help tackling tough challenges will have access to a group of curated mentors from the Mercury network and gain insights and guidance tailored to their needs. Speakers on the panel "An Intro to Central Texas Seed Stage VCs” include: Eric Engineer, S3 Ventures; Rajiv Bala, Clutch Ventures; Cat Dizon, Active Capital; Mike Marcantonio, LiveOak; and moderator Aziz Gilani, Mercury.

This event is Tuesday, July 9, from 3:30 to 7 pm at The Ion. Click here to register.

July 9 — Tech+Tequila Talk: The Future of Tokenization and Capital Raising

Guest speaker, Ed Nwokedi, the Founder and CEO of RedSwan CRE Marketplace will unpack the process of converting ownership rights in an asset into digital tokens on a blockchain, how tokenization allows for fractional ownership, and the impact these innovations can have on capital raising and asset management.

This event is Tuesday, July 9, from 8 to 8 pm at Esperson Building. Click here to register.

July 11 — Out in Tech Mixer

Out in Tech Houston provides an inclusive networking space for LGBTQ+ people and allies working in tech. Check out this relaxed, social-mixer event, hosted on the second Thursday of every month.

This event is Thursday, July 11, from 7 to 8:30 pm at Second Draught. Click here to register.

July 15 — 2024 Young Leaders Institute: Renewable Energy and Climate Solutions

Asia Society Texas' Young Leaders Institute (YLI) is a week-long summer program for high school students that promotes global competence, elevates leadership skills, and connects students from across diverse backgrounds and experiences. The Institute invites students to explore some of the most timely, relevant global issues for young leaders today.

This event starts Monday, July 15, from 8:30 am to 12:30 pm at the Asia Society Texas Center. Click here to register.

July 17 — Open Project Night at Impact Hub Houston

A chance to work on solutions for some of Houston’s most pressing issues, the theme of this month's meeting will be gender equality. Network and workshop pitching materials with likeminded entrepreneurs.

This event is Wednesday, July 17, from 5:30 to 8 pm at 808 Travis St. Click here to register.

July 18 — First of a Kind (FOAK) Networking Lunch

Inspired by the recent FOAK Roundtable hosted by Deanna Zhang, the Energy Underground team of professionals are diving deep into the world of innovative initiatives. Whether you're a seasoned professional or just dipping your toes into the realm of groundbreaking projects, this lunch is for you. The Energy Underground is a group of professionals in the Greater Houston area that are accelerating the Energy Transition.

This event is Thursday, July 18, from 12 to 1 pm at The Cannon West Houston. Click here to register.

July 20 — FIONA: 5th Annual HACKATHON

Get ready for a day filled with coding challenges, teamwork, and innovation. Whether you're a seasoned coder or just starting out, this event is great for anyone passionate about technology and creativity. Go in person a day of brainstorming, coding, and presenting your projects to a panel of judges. Collaborate with fellow hackers, learn new skills, and showcase your talents.

This event is Saturday, July 20, from 11 am to 2 pm at 15500 Voss Rd. Click here to register.

July 24 — Houston Methodist Clinician Speaker Series

Dr. Desai, Vice President, Chief Operating Officer, and Chief Medical Officer & Chief Quality Officer at Houston Methodist Cypress Hospital, will discuss the plans for Houston Methodist's ninth hospital which is scheduled to open in early 2025.

Agenda:

4:30pm - Arrival & Registration

5:00pm - Presentation by Dr. Desai

5:30pm - Audience discussion

6:00pm - Event concludes

This event is Wednesday, July 24, from 4:30 to 6 pm at The Ion. Click here to register.

July 25 — DivInc Demo Day: Sports Tech Spring 2024

The Spring 2024 Sports Tech Demo Day will be a celebration and showcase of the growth of founders using technology to enhance human performance, fan experience, fantasy sports & betting, future of media, NIL innovation (i.e. Name, Image, Likeness), and stadium & venue innovation.

This event is Thursday, July 25, from 6:30 to 7:30 pm at The Ion. Click here to register.

July 30 — Texas Small Business Expo

Texas Small Business Expo is a trade show, educational business to business conference, exhibition & networking event for entrepreneurs, start-ups and anyone who owns a business. Network, build new business relationships, and learn from industry experts on how to enhance your business.

This event is Tuesday, July 30, from 4 to 9 pm at Wakefield Crowbar. Click here to register.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

UH med school gets $2M gift and more top Houston innovation news

Trending Topics

Editor's note: The top Houston innovation news of the month is full of fresh funding, with two Texas medical schools receiving major gifts — one of historic proportions. Below are the five most-read InnovationMap headlines from April 16-30, 2026.

UH med school granted $2M gift to offer student scholarships

A new scholarship endowment aims to support students in the University of Houston’s recently established medical school. The University of Houston’s Tilman J. Fertitta Family College of Medicine received a planned estate gift commitment estimated at $2.1 million to establish the Bob Diehl and Teresa Evans Diehl Scholarship Endowment. The scholarship will assist full-time medical students who demonstrate financial need and meet academic standards. Continue reading.

How Houston innovators played a role in the historic Artemis II splashdown

Research from Rice University played a critical role in the safe return of U.S. astronauts aboard NASA’s Artemis II mission this month. Rice mechanical engineer Tayfun E. Tezduyar and longtime collaborator Kenji Takizawa developed a key computational parachute fluid-structure interaction (FSI) analysis system that proved vital in NASA’s Orion capsule’s descent into the Pacific Ocean. The FSI system, originally developed in 2013 alongside NASA Johnson Space Center, was critical in Orion’s three-parachute design, which slowed the capsule as it returned to Earth, according to Rice. Continue reading.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March. Dr. Ryan S. Dhindsa hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation. Continue reading.

New UT Austin med center, anchored by MD Anderson, gets historic gift

A donation announced April 21 breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release. Continue reading.

Houston VC funding surged nearly 50% in Q1 2026, report says

Houston saw a jump in VC funding in Q1 2026, fueled by several major investments in clean energy startups. Image via Getty Images

First-quarter venture capital funding for Houston-area startups climbed nearly 50 percent compared to the same time last year, according to the PitchBook-NVCA Venture Monitor. In Q1 2026, Houston-area startups raised $532.3 million, a 49 percent jump from $320.2 million in Q1 2025, according to the PitchBook-NVCA Venture Monitor. However, the Q1 total fell 23 percent from the $671.05 million raised in Q4 2025. Continue reading.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”

View All Listings